Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 70/100

Failure Rate

5.0%

1 terminated/withdrawn out of 20 trials

Success Rate

50.0%

-36.5% vs industry average

Late-Stage Pipeline

15%

3 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

7 recruiting

Enrollment Performance

Analytics

N/A
7(70.0%)
Phase 4
2(20.0%)
Phase 3
1(10.0%)
10Total
N/A(7)
Phase 4(2)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (20)

Showing 20 of 20 trials
NCT07560514Not ApplicableRecruiting

Assessment of Digital Technologies for Detection of Dental Caries

Role: lead

NCT07338929Recruiting

Physical Performance Assessment in Kidney Transplant Evaluation

Role: lead

NCT07275541Recruiting

Platelet Aggregation in the Diagnosis of Acute Graft Rejection

Role: lead

NCT07274462Phase 4Active Not Recruiting

DARA-MVI Study (Daratumumab for Microvascular Inflammation in Kidney Transplantation)

Role: lead

NCT07081126Not ApplicableRecruiting

Daratumumab for Late Antibody-Mediated Rejection

Role: lead

NCT07055984Recruiting

Predicting Outcomes in Posttransplant Diabetes Mellitus Via microRNA

Role: lead

NCT07024238Not ApplicableEnrolling By Invitation

Impact of SCFA Supplementation on Gut Microbiome Composition of Kidney Transplant Recipients

Role: lead

NCT07025122Enrolling By Invitation

Fatigue in Multiple Sclerosis and Its Relationship to Inflammatory and Neurodegenerative Markers of the Disease

Role: lead

NCT06951581Not ApplicableCompleted

Impact of SCFA Supplementation on Metabolic Profiles in Serum and Urine of Kidney Transplant Recipients.

Role: lead

NCT06950931Enrolling By Invitation

Posttranslationally Modified Fetuin-A in Urine as a Marker for Renal Dysfunction (Patients With Chronic Kidney Disease - With or Without Kidney Transplantation).

Role: lead

NCT06929637Not ApplicableNot Yet Recruiting

Amino Acid Infusion in Kidney Transplant Recipients

Role: lead

NCT06801886Phase 3Enrolling By Invitation

Silymarin's Advantage on Graft Effectiveness

Role: lead

NCT06426030Recruiting

Validation of Czech Language Versions of Questionnaires for ALS Patients' Functional Status and Biomarker Long-term Follow-up

Role: collaborator

NCT03094715Not ApplicableTerminated

Efficacy and Safety of Thrombectomy in Stroke With Extended Lesion and Extended Time Window

Role: collaborator

NCT02419365Recruiting

International Primary Ciliary Dyskinesia (PCD) Registry

Role: collaborator

NCT04717115Unknown

Genotype/Phenotype Correlation With Focus on Lung Function in Primary Ciliary Dyskinesia (PCD)

Role: collaborator

NCT04949308Unknown

Nasal Nitric Oxide Across Mutations in Primary Ciliary Dyskinesia

Role: collaborator

NCT04735107Not ApplicableUnknown

Mucosal Flap Reinforced Colorectal Anastomosis and Trans-Anal Vacuum Drainage: A Feasibility Study

Role: collaborator

NCT02216370Unknown

Detection of Occult Paroxysmal AF in Cryptogenic Stroke or TIA Patients Using an Implantable Loop Recorder and Correlation With Genetic Markers.

Role: lead

NCT01862978Phase 4Unknown

Safety and Efficacy of Heparin and Nadroparin in the Acute Phase of Ischemic Stroke

Role: lead

All 20 trials loaded